Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 17, 2016

Study Completion Date

November 17, 2016

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

IPH2102 at 0.1 mg/kg

every 3 months

DRUG

IPH2102 at 1 mg/kg

every 4 weeks

DRUG

Placebo (normal saline solution)

every 4 weeks

Trial Locations (43)

13273

Institut Paoli - Calmettes, Marseille

25030

CHU de Besançon, Besançon

29609

Hôpital Morvan CHU Brest, Brest

30029

CHU Caremeau, Nîmes

31059

CHU Purpan, Toulouse

33604

CHU de Bordeaux - Hôpital Haut-Lévêque, Pessac

34295

CHU Saint Eloi, Montpellier

34500

CHG de Béziers, Béziers

38043

CHU de Grenoble, Grenoble

41000

CH de Blois, Blois

44000

CHU de Nantes, Nantes

45067

CHR d'Orléans, Orléans

49933

CHU Angers, Angers

51092

CHU de Reims, Reims

54511

CHU de Nancy Hôpitaux de Brabois, Vandœuvre-lès-Nancy

59037

Hôpital Claude Huriez, Lille

59322

CH Valenciennes, Valenciennes

63003

CHU Estaing, Clermont-Ferrand

64100

Centre hospitalier de la côte Basque, Bayonne

66000

CH Saint-Jean, Perpignan

67098

Hôpital Haute Pierre et Hôpital Civil, Strasbourg

68100

Centre Hospitalier de Mulhouse, Mulhouse

69495

Centre hospitalier Lyon Sud, Pierre-Bénite

74374

CHR d'Annecy, Pringy

75010

Hôpital Saint-Louis, Paris

75012

Hôpital Saint-Antoine, Paris

75743

Hôpital Necker, Paris

76038

Centre Henri Becquerel, Rouen

77104

CH de Meaux, Meaux

78157

Centre Hospitalier de Versailles, Le Chesnay

80054

CHU d'Amiens, Amiens

86021

CHU de Poitiers, Poitiers

87042

CHU de Limoges, Limoges

91100

Centre hospitalier sud francilien, Corbeil-Essonnes

92141

Hôpital Militaire Percy, Clamart

92210

Centre René Huguenin, Saint-Cloud

93000

Hôpital Avicenne, Bobigny

94010

Hôpital Henri Mondor, Créteil

94805

Institut Gustave Roussy, Villejuif

95107

Centre hospitalier Victor Dupouy, Argenteuil

95303

CH René Dubos, Cergy-Pontoise

06189

Centre Antoine Lacassagne, Nice

02321

CH Saint-Quentin, Saint-Quentin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Innate Pharma

INDUSTRY

NCT01687387 - Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR) | Biotech Hunter | Biotech Hunter